EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016–2023

Twan Sia iD, Farah Abou-Taleb iD, Connie Ma, Shufeng Li, Anne Lynn S Chang iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0340907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Twan Sia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Stanford University School of Medicine, Redwood City, California, United States of America. Hauptthemen laut MEDLINE: Acanthosis Nigricans, Transgender Persons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stanford Medical Student Association, Stanford MedScholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acanthosis nigricans (AN) is a highly visible cutaneous condition that has been associated with cardiometabolic factors, drugs, or malignancy in various populations. AN can be challenging to treat. Transmasculine patients are a special population, but their AN prevalence, and whether AN associates with demographic factors, co-morbidities and gender affirming care (GAC) treatment types have not been well-studied. Our study explores whether GAC treatment type is associated with AN while controlling for confounders in a large group of transmasculine patients at an academic center.

Methods

Following Institutional Review Board approval, the Stanford Research Repository (01/01/2016–21/09/2023) was searched to identify transmasculine patients for individual chart review. The primary outcome was AN and its association with demographic factors, co-morbidities, and gender-affirming care (GAC) treatment type by multivariate logistic regression (presented as Odds Ratio (OR) and 95% Confidence Interval (CI)).

Results

Out of 945 transmasculine patients, AN prevalence was 4.55%, an elevated rate compared to the overall database prevalence of 0.3% for the same period. Prevalence of AN in transmasculine patients never exposed to GAC was 4.02% (7/174). Median age was 20.1 years (interquartile range (IQR) 17.2–25.4). On multivariate logistic regression, AN was associated with obesity (OR 9.31, 95% CI 4.40–20.33), metabolic syndrome (OR 4.04, 95% CI 1.09–15.23), prediabetes (OR 3.17, 95% CI 1.10–8.54), hypertension (OR 2.74, 95% CI 0.96–7.18), and Hispanic ethnicity (OR 2.46, 95% CI 1.12–5.25). GAC type (including exogenous testosterone usage) was not associated with AN, despite >99% power to detect a 10% difference in AN prevalence.

Conclusions

Because AN is enriched in transmasculine patients, and precedes co-morbidities in a majority of cases, dermatologists and other physicians should consider examination of common areas for AN in in transmasculine patients, as screening and diagnosis of co-morbidities could lead to improved health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acanthosis NigricansTransgender PersonsHumansMaleFemalePrevalenceAdultComorbidityMiddle AgedCross-Sectional StudiesGender-Affirming CareYoung AdultAdolescent

Autor:innen und Institutionen

  • Department of Dermatology, Stanford University School of Medicine, Redwood City, California, United States of America.
  • Department of Urology, Stanford University School of Medicine, Palo Alto, California, United States of America.

ORCID-Profile: Twan Sia, Farah Abou-Taleb, Anne Lynn S Chang

Förderung

  • Stanford Medical Student Association
  • Stanford MedScholars

Zitieren

APA

Sia, T., Abou-Taleb, F., Ma, C., Li, S., & Chang, A. L. S. (2026). Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016–2023. PLOS One. https://doi.org/10.1371/journal.pone.0340907

Vancouver

Sia T, Abou-Taleb F, Ma C, Li S, Chang ALS. Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016–2023. PLOS One. 2026. doi:10.1371/journal.pone.0340907

BibTeX
@article{Sia2026,
  author = {Sia, Twan and Abou-Taleb, Farah and Ma, Connie and Li, Shufeng and Chang, Anne Lynn S},
  title = {Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016–2023},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0340907}
}
Kostenlos starten →